Deborah S. Yokoe*

, Gary A. Noskin†, Susan M. Cunningham†, Gianna Zuccotti‡, Theresa Plaskett‡, Victoria J. Fraser§, Margaret A. Olsen§, Jerome I. Tokars¶, Steven Solomon¶, Trish M. Perl#, Sara E. Cosgrove#, Richard S. Tilson*, Maurice Greenbaum**, David C. Hooper††, Kenneth E. Sands‡‡, John Tully§§, Loreen A. Herwaldt¶¶, Daniel J. Diekema¶¶, Edward S. Wong##, Michael Climo##, and Richard Platt***
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Northwestern University, Chicago, Illinois, USA; ‡Memorial Sloan-Kettering Cancer Center, New York, New York, USA; §Washington University School of Medicine, St. Louis, Missouri, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; **North Shore Medical Center-Salem Hospital, Salem, Massachusetts, USA; ††Massachusetts General Hospital, Boston, Massachusetts, USA; ‡‡Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; §§Mount Auburn Medical Center, Cambridge, Massachusetts, USA; ¶¶University of Iowa Carver College of Medicine, Iowa City, Iowa, USA; ##McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA; ***Harvard Pilgrim Health Care, Boston, Massachusetts, USA
Main Article
Table A7
Percentage of patients who underwent cesarean delivery and who met the antimicrobial exposure or diagnosis code screening criteria
| Hospital |
% of cesarean deliveries with
|
| 2-day antimicrobial
exposure criterion |
Diagnosis code criteria |
2-day antimicrobial exposure
or diagnosis code criteria |
| 1A |
7.9 |
3.8 |
9.2 |
| 1B |
9.1 |
3.3 |
9.4 |
| 1C |
8.8 |
3.5 |
9.7 |
| 1D |
8.5 |
0 |
8.5 |
| 1E |
9.4 |
3.5 |
9.9 |
| Pooled |
8.8 |
3.2 |
9.5 |
| 2A |
7.0 |
7.5 |
9.4 |
| 2B |
6.5 |
3.3 |
7.7 |
| 2C |
27.4 |
11.8 |
28.6 |
| 2D |
20.0 |
9.2 |
21.2 |
| Pooled |
12.7 |
6.4 |
14.1 |
Main Article
Top of Page